Although the following is longer than usual, I think that the time invested in reading it will be well worth it.
I have now read about the following Danish study on two different sites, and so I have to believe that what I am going to discuss is indeed true. Initially, I found this story to be so incredible, that I assumed that it was some sort of “fake news,” but it seems that it is not fake, but true!.
While what I am going to spell out is from a Danish study, and one has to wonder if anything at all similar occurred in the U.S.
Most of the following is taken from Epoch News, but, to repeat, this is the second time I have seen this info:
A recent Danish study showed enormous variation in the adverse events associated with different batches of the Pfizer-BioNTech vaccine or BNT162b2 per its scientific codename.
In an impressive and easy to understand graph, the batches used in Denmark essentially break down into three groups. As is apparent from the color coded graphic display, these three different group batches are dramatically different as they are each graphically displayed versus side effects. (For ease of understanding these groups are blue, green, and yellow.)
The graphed line that represents the green batch is the batch that was used the most in Denmark. The green batch of vaccine represented about 60+% of the total number of doses, and the total number of individuals who received the green batch was huge.
The point on that graphed green line furthest to the right represents somewhat over 800,000 doses that were administered. These 800,000 doses are associated with around 2,000 suspected adverse events, which gives a reporting rate of one suspected adverse event per approximately 400 doses. As a noted German scientist, Gerald Dyker, put it when speaking about adverse effects, “That’s not a small amount if we compare to what we know otherwise from influenza vaccines.”
There are then the “blue batches” clustered around the blue line on the graphic display. These blue batches are associated with an extraordinarily high level of adverse events. As Dyker notes, no more than 80,000 doses of any of the blue batches were administered in Denmark—suggesting that these especially bad batches may perhaps have been quietly pulled from the market by public health authorities.
Nonetheless, these batches had as many as 8,000 suspected adverse events associated with them. Eight thousand out of 80,000 doses would give a reporting rate of one suspected adverse event for every ten doses—and Dyker notes that some of the blue batches are indeed associated with a reporting rate of as high as one suspected adverse event for every six doses!
On Dyker’s calculation, the blue batches represent less than 5 percent of the total number of doses included in the Danish study. Nonetheless, they are associated with nearly 50 percent of the 579 deaths recorded in the sample.
Finally, we have the “yellow batches” clustered around the yellow line on the graph. Each yellow dot on the graph represents from 100,00 – 500,000 vaccine doses. The yellow batches represent around 30 percent of the total, and are associated with literally zero suspected adverse events.
As Dyker puts it, “malicious” observers might note that “this is how placebos would look.”
And malicious observers might be right. For professors Dyker and Matysik compared the batch numbers contained in the Danish study with publicly available information on the batches approved for release, and they made the startling discovery that almost none of the harmless yellow batches, unlike the very-bad blue batches, and not-so-bad green batches, appear to have been subject to any quality-control testing at all.
In short, to paraphrase the German scientists’ findings on the variability of the Pfizer-BioNTech batches, it would appear that the good was bad, the bad was very bad, and the very good was saline solution.
To me the findings in this Danish study are not only amazing but frightening! Being the inquisitive contrarian that I am, I have to wonder if any similar study of batch variations was done in the U.S. … and if not, why not?
7/7/23
californiacontrarian